The growth of siRNA-based therapeutics: Updated clinical studies

MM Zhang, R Bahal, TP Rasmussen… - Biochemical …, 2021 - Elsevier
More than two decades after the natural gene-silencing mechanism of RNA interference was
elucidated, small interfering RNA (siRNA)-based therapeutics have finally broken into the …

Therapeutic siRNA: state of the art

B Hu, L Zhong, Y Weng, L Peng, Y Huang… - Signal transduction and …, 2020 - nature.com
ABSTRACT RNA interference (RNAi) is an ancient biological mechanism used to defend
against external invasion. It theoretically can silence any disease-related genes in a …

The molecular basis of retinal ganglion cell death in glaucoma

M Almasieh, AM Wilson, B Morquette… - Progress in retinal and …, 2012 - Elsevier
Glaucoma is a group of diseases characterized by progressive optic nerve degeneration that
results in visual field loss and irreversible blindness. A crucial element in the …

The race of 10 synthetic RNAi-based drugs to the pharmaceutical market

R Titze-de-Almeida, C David… - Pharmaceutical …, 2017 - Springer
Ten years after Fire and Melo's Nobel Prize for discovery of gene silencing by double-
stranded RNA, a remarkable progress was achieved in RNA interference (RNAi). Changes …

[HTML][HTML] Stem cell treatment of degenerative eye disease

B Mead, M Berry, A Logan, RAH Scott, W Leadbeater… - Stem cell …, 2015 - Elsevier
Stem cell therapies are being explored extensively as treatments for degenerative eye
disease, either for replacing lost neurons, restoring neural circuits or, based on more recent …

Retinal ganglion cell repopulation for vision restoration in optic neuropathy: a roadmap from the RReSTORe Consortium

JR Soucy, EA Aguzzi, J Cho, MJ Gilhooley… - Molecular …, 2023 - Springer
Retinal ganglion cell (RGC) death in glaucoma and other optic neuropathies results in
irreversible vision loss due to the mammalian central nervous system's limited regenerative …

Insulin restores retinal ganglion cell functional connectivity and promotes visual recovery in glaucoma

S El Hajji, Y Shiga, N Belforte, YC Solorio, O Tastet… - Science …, 2024 - science.org
Dendrite pathology and synaptic loss result in neural circuit dysfunction, a common feature
of neurodegenerative diseases. There is a lack of strategies that target dendritic and …

[HTML][HTML] Intravitreally transplanted dental pulp stem cells promote neuroprotection and axon regeneration of retinal ganglion cells after optic nerve injury

B Mead, A Logan, M Berry, W Leadbeater… - … & visual science, 2013 - arvojournals.org
Purpose.: To investigate the potential therapeutic benefit of intravitreally implanted dental
pulp stem cells (DPSCs) on axotomized adult rat retinal ganglion cells (RGCs) using in vitro …

RNA-targeting strategies as a platform for ocular gene therapy

S Kumar, LE Fry, JH Wang, KR Martin… - Progress in Retinal and …, 2023 - Elsevier
Genetic medicine is offering hope as new therapies are emerging for many previously
untreatable diseases. The eye is at the forefront of these advances, as exemplified by the …

The role of caspase-2 in regulating cell fate

V Vigneswara, Z Ahmed - Cells, 2020 - mdpi.com
Caspase-2 is the most evolutionarily conserved member of the mammalian caspase family
and has been implicated in both apoptotic and non-apoptotic signaling pathways, including …